COVID-19 Clinical Trials in Chicago

Showing 81-100 of 166 trials

Registry of CytoSorb Therapy in COVID-19 ICU Patients

NCT04391920

The CTC Registry collects patient-level clinical data on CytoSorb hemoadsorption provided to COVID-19 ICU patients via integration of the CytoSorb device into ECMO, CRRT, or hemoperfusion extracorporeal circuits. The intent of the registry is to gain understanding on how CytoSorb hemoadsorption provides clinical benefit to COVID-19 ICU patients.

COVID-19

CytoSorbents, Inc138 participantsStarted Aug 2020

Aurora, Colorado, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +4 more locations

TERMINATEDPhase 12.2 miles

Leflunomide in Mild COVID-19 Patients

NCT04361214

This study aims to examine the tolerability of high dose of leflunomide in patients with COVID-19 who are being managed in the outpatient setting.

COVID-19

University of Chicago11 participantsStarted May 2020

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

NCT04516746

The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

COVID-19SARS-CoV-2

AstraZeneca32,450 participantsStarted Aug 2020

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +81 more locations

Registry of CytoSorb Therapy in COVID-19 ICU Patients

Leflunomide in Mild COVID-19 Patients

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

COVID-19 Trials in Other Cities

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Bucillamine in Treatment of Patients With COVID-19

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Study of Sargramostim in Patients With COVID-19

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

A Trial of NT-I7 in COVID-19 (SPESELPIS)

MP1032 Treatment in Patients With Moderate to Severe COVID-19

COVID-19 and Anti-CD14 Treatment Trial

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

Examine the Psychosocial Impacts of COVID-19 Pandemic.

Other Conditions in Chicago